For research use only. Not for human or veterinary use. Not for diagnostic or therapeutic use.
Menu
Reconstitution calculator

Cited duration

Cagrilintide study duration

The study cited for Cagrilintide lasted 26 weeks. It is a study duration, not a recommended cycle, and no off period is stated. Population in the source: Adults with overweight or obesity, phase 2 dose-finding trial (706 adults assigned to cagrilintide).[1]

Human trial

Sam, MBA · Human-researched and AI-assisted with full editorial review.

About the source: Trial duration: once weekly for 26 weeks including a dose-escalation period of up to 6 weeks. Study duration, not a recommended cycle; no off period.

Study duration

26 weeks[1] Human trial

Duration of the cited study. It describes the source and is not a recommended cycle; no off period is stated. Source

References

Numbered sources used on this page. Markers in the text link here.

  1. Phase 2 dose-finding trial (Lancet 2021, doi 10.1016/S0140-6736(21)01751-7; NCT03856047; 706 adults assigned to cagrilintide) pubmed.ncbi.nlm.nih.gov Human trial